178 related articles for article (PubMed ID: 16675557)
1. Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia.
Graham DK; Salzberg DB; Kurtzberg J; Sather S; Matsushima GK; Keating AK; Liang X; Lovell MA; Williams SA; Dawson TL; Schell MJ; Anwar AA; Snodgrass HR; Earp HS
Clin Cancer Res; 2006 May; 12(9):2662-9. PubMed ID: 16675557
[TBL] [Abstract][Full Text] [Related]
2. Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase.
Keating AK; Salzberg DB; Sather S; Liang X; Nickoloff S; Anwar A; Deryckere D; Hill K; Joung D; Sawczyn KK; Park J; Curran-Everett D; McGavran L; Meltesen L; Gore L; Johnson GL; Graham DK
Oncogene; 2006 Oct; 25(45):6092-100. PubMed ID: 16652142
[TBL] [Abstract][Full Text] [Related]
3. Mer tyrosine kinase promotes the survival of t(1;19)-positive acute lymphoblastic leukemia (ALL) in the central nervous system (CNS).
Krause S; Pfeiffer C; Strube S; Alsadeq A; Fedders H; Vokuhl C; Loges S; Waizenegger J; Ben-Batalla I; Cario G; Möricke A; Stanulla M; Schrappe M; Schewe DM
Blood; 2015 Jan; 125(5):820-30. PubMed ID: 25428221
[TBL] [Abstract][Full Text] [Related]
4. [Expression of Mer on Jurkat cells and its anti-apoptosis effect].
Fan L; Dai L; Shen F; Zhou MY; Dong NZ; Ruan CG
Ai Zheng; 2007 Jul; 26(7):698-702. PubMed ID: 17626743
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia.
Lee-Sherick AB; Eisenman KM; Sather S; McGranahan A; Armistead PM; McGary CS; Hunsucker SA; Schlegel J; Martinson H; Cannon C; Keating AK; Earp HS; Liang X; DeRyckere D; Graham DK
Oncogene; 2013 Nov; 32(46):5359-68. PubMed ID: 23474756
[TBL] [Abstract][Full Text] [Related]
6. Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia.
Linger RM; DeRyckere D; Brandão L; Sawczyn KK; Jacobsen KM; Liang X; Keating AK; Graham DK
Blood; 2009 Sep; 114(13):2678-87. PubMed ID: 19643988
[TBL] [Abstract][Full Text] [Related]
7. UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo.
Christoph S; Deryckere D; Schlegel J; Frazer JK; Batchelor LA; Trakhimets AY; Sather S; Hunter DM; Cummings CT; Liu J; Yang C; Kireev D; Simpson C; Norris-Drouin J; Hull-Ryde EA; Janzen WP; Johnson GL; Wang X; Frye SV; Earp HS; Graham DK
Mol Cancer Ther; 2013 Nov; 12(11):2367-77. PubMed ID: 23997116
[TBL] [Abstract][Full Text] [Related]
8. Mer receptor tyrosine kinase is a therapeutic target in pre-B-cell acute lymphoblastic leukemia.
Linger RM; Lee-Sherick AB; DeRyckere D; Cohen RA; Jacobsen KM; McGranahan A; Brandão LN; Winges A; Sawczyn KK; Liang X; Keating AK; Tan AC; Earp HS; Graham DK
Blood; 2013 Aug; 122(9):1599-609. PubMed ID: 23861246
[TBL] [Abstract][Full Text] [Related]
9. Combined expression of pTalpha and Notch3 in T cell leukemia identifies the requirement of preTCR for leukemogenesis.
Bellavia D; Campese AF; Checquolo S; Balestri A; Biondi A; Cazzaniga G; Lendahl U; Fehling HJ; Hayday AC; Frati L; von Boehmer H; Gulino A; Screpanti I
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3788-93. PubMed ID: 11891328
[TBL] [Abstract][Full Text] [Related]
10. Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-kappaB.
Georgescu MM; Kirsch KH; Shishido T; Zong C; Hanafusa H
Mol Cell Biol; 1999 Feb; 19(2):1171-81. PubMed ID: 9891051
[TBL] [Abstract][Full Text] [Related]
11. Tandem duplication of the FLT3 gene in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual disease.
Nakao M; Janssen JW; Erz D; Seriu T; Bartram CR
Leukemia; 2000 Mar; 14(3):522-4. PubMed ID: 10720156
[No Abstract] [Full Text] [Related]
12. bcl-2 proto-oncogene expression during human T cell development. Evidence for biphasic regulation.
Gratiot-Deans J; Ding L; Turka LA; Nuñez G
J Immunol; 1993 Jul; 151(1):83-91. PubMed ID: 8326141
[TBL] [Abstract][Full Text] [Related]
13. Cloning and mRNA expression analysis of a novel human protooncogene, c-mer.
Graham DK; Dawson TL; Mullaney DL; Snodgrass HR; Earp HS
Cell Growth Differ; 1994 Jun; 5(6):647-57. PubMed ID: 8086340
[TBL] [Abstract][Full Text] [Related]
14. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
Wingett D; Long A; Kelleher D; Magnuson NS
J Immunol; 1996 Jan; 156(2):549-57. PubMed ID: 8543805
[TBL] [Abstract][Full Text] [Related]
15. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study.
Bash RO; Hall S; Timmons CF; Crist WM; Amylon M; Smith RG; Baer R
Blood; 1995 Jul; 86(2):666-76. PubMed ID: 7605997
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia.
Zhu YM; Das-Gupta EP; Russell NH
Blood; 1999 Jul; 94(2):733-40. PubMed ID: 10397740
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia.
Coustan-Smith E; Kitanaka A; Pui CH; McNinch L; Evans WE; Raimondi SC; Behm FG; Aricò M; Campana D
Blood; 1996 Feb; 87(3):1140-6. PubMed ID: 8562940
[TBL] [Abstract][Full Text] [Related]
18. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2.
Delia D; Aiello A; Formelli F; Fontanella E; Costa A; Miyashita T; Reed JC; Pierotti MA
Blood; 1995 Jan; 85(2):359-67. PubMed ID: 7811993
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ABL1 expression in adult T-cell acute lymphoblastic leukemia by oligonucleotide array analysis.
Chiaretti S; Tavolaro S; Ghia EM; Ariola C; Matteucci C; Elia L; Maggio R; Messina M; Ricciardi MR; Vitale A; Ritz J; Mecucci C; Guarini A; Foà R
Haematologica; 2007 May; 92(5):619-26. PubMed ID: 17488685
[TBL] [Abstract][Full Text] [Related]
20. G1/S transcriptional networks modulated by the HOX11/TLX1 oncogene of T-cell acute lymphoblastic leukemia.
Riz I; Hawley RG
Oncogene; 2005 Aug; 24(36):5561-75. PubMed ID: 15897879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
